Transcription of NASPGHAN Clinical Practice Guideline for the Diagnosis and ...
{{id}} {{{paragraph}}}
Copyright ESPGHAL and NASPGHAN . All rights Clinical Practice Guideline for the Diagnosisand Treatment of nonalcoholic fatty liver Diseasein Children: Recommendations from the ExpertCommittee on NAFLD (ECON) and the North AmericanSociety of Pediatric Gastroenterology, Hepatologyand Nutrition ( NASPGHAN ) yMiriam B. Vos,z Stephanie H. Abrams,z Sarah E. Barlow,jjSonia Caprio, #Stephen R. Daniels, yyRohit Kohli,zz Marialena Mouzaki,jjjj Pushpa Sathya,## Jeffrey B. Schwimmer, #Shikha S. Sundaram, and yyStavra A. XanthakosABSTRACTN onalcoholic fatty liver disease (NAFLD) is a highly prevalent chronic liverdisease that occurs in the setting of insulin resistance and increased adiposity. Ithas rapidly evolved into the most common liver disease seen in the pediatricpopulation and is a management challengefor general pediatric practitioners,subspecialists, and for health systems. In this Guideline , the expert committee onNAFLD reviewed and summarized the available literature, formulating recom-mendations to guide screening and Clinical care of children with Words:children, nonalcoholic fatty liver disease , recommendations,treatment(JPGN2017;64: 319 334) nonalcoholic fatty liver disease (NAFLD) is a chronic liverdisease resulting from excessive fat accumulation in theliver.
Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent chronic liver disease that occurs in the setting of insuli n resistance and increased adiposity. It has rapidly evolved into the most comm on liver disease seen in the pediatric
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Non-Alcoholic Fatty Liver Disease NAFLD, Nonalcoholic fatty, Disease, Nonalcoholic fatty liver disease, Liver, Nonalcoholic Fatty Liver Disease and Nonalcoholic, Fatty Liver, Liver disease, Non-Alcoholic, Nonalcoholic fatty liver disease NAFLD, Nonalcoholic fatty liver disease and, Nonalcoholic, EASO Clinical Practice Guidelines for the, Non-alcoholic fatty liver disease, Nonalcoholic steatohepatitis